• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Ulthera Inc.

Medtronic shareholder sues to block pending merger with Covidien | The week in medtech M&A

July 30, 2014 By MassDevice Leave a Comment

Report: Medtronic shareholder sues to block Covidien merger

July 24, 2014 by Brad Perriello

Filed Under: Mergers & Acquisitions, News Well Tagged With: Covidien, Elekta, Merz, Mesi Medikal, Ulthera Inc., Visualase

Ulthera pulls $86M IPO in favor of $600M merger

July 23, 2014 By Arezu Sarvestani Leave a Comment

Ulthera pulls IPO in favor of merger

Arizona device maker Ulthera is ditching its planned initial public offering in favor of a $600 million merger with larger aesthetics company Merz Inc., according to an SEC filing.

Filed Under: Cosmetic/Aesthetic, Initial Public Offering (IPO), Mergers & Acquisitions, News Well, Ultrasound Tagged With: Merz, Ulthera Inc.

Intuitive Surgical cleared by FDA for single-site da Vinci Sp robotic surgery system | Medtech regulatory news for the week of Apr. 28, 2014

April 29, 2014 By MassDevice Leave a Comment

FDA clears Intuitive Surgical's single-site da Vinci Sp robotic surgery system

April 22, 2014 by Brad Perriello

Filed Under: Food & Drug Administration (FDA), News Well, Regulatory/Compliance Tagged With: Intuitive Surgical, Judge Rotenberg Center, NASDAQ, Ulthera Inc.

Ulthera registers for $86M IPO

April 22, 2014 By Brad Perriello Leave a Comment

Ulthera registers for $86M IPO

Ulthera filed for a U.S. initial public offering yesterday, saying it hopes to raise as much as $86 million when it debuts on the NASDAQ stock exchange.

Mesa, Ariz.-based Ulthera makes an ultrasound device, which is designed to use the body’s natural healing process to non-invasively lift and tighten loose skin on the neck and under the chin.

Filed Under: Cosmetic/Aesthetic, Initial Public Offering (IPO), News Well, Regulatory/Compliance Tagged With: NASDAQ, Ulthera Inc.

Ulthera lands U.S. patent for energy-based treatment of sweating disorders

October 15, 2012 By MassDevice staff Leave a Comment

Ulthera logo

Aesthetic devices maker Ulthera won a new U.S. patent for an ultrasound-based therapy for treating sweat glands disorders, such as hyperhidrosis

The patent, titled "Methods for treatment of sweat glands" was granted by the U.S. Patent & Trademark Office late last week, according to a press release.

Filed Under: Cosmetic/Aesthetic, News Well Tagged With: U.S. Patent & Trademark Office (USPTO), Ulthera Inc.

Ulthera’s ultrasound system lands FDA OK to “tighten turkey necks and smooth out double chins”

October 10, 2012 By MassDevice staff Leave a Comment

Ulthera logo

Arizona- based medical device company Ulthera won FDA clearance for its ultrasound platform device, which is designed to use the body’s natural healing process to non-invasively lift and tighten loose skin on the neck and under the chin.

The Ulthera System combines ultrasound imaging with focused ultrasound therapy, representing the only energy-based device with an indication to "tighten turkey necks and smooth out double-chins," the company said.

Filed Under: 510(k), Cosmetic/Aesthetic, News Well Tagged With: Ulthera Inc.

HeartWare lands FDA OK for extended trial ahead of PMA review | Regulatory Roundup

March 19, 2012 By MassDevice staff Leave a Comment

MassDevice.com Regulatory Roundup

 HeartWare lands approval for a 4th round of pivotal trials for its HVAD ventricular assist device

Filed Under: Food & Drug Administration (FDA), News Well, Pre-Market Approval (PMA) Tagged With: Biovo Technologies, Boston Scientific, Cambridge Heart Inc., Cardiac Rhythm Management, Clinical Trials, Cytori Therapeutics, HeartWare International Inc., Regulatory Roundup, Sunshine Heart Inc., SurgiTools, Ulthera Inc.

Tengion names John Miclot CEO following tough Q3 | Personnel Moves

December 7, 2011 By MassDevice staff Leave a Comment

Tengion CEO John Miclot

Tengion Inc. (NSDQ:TNGN) handed veteran med-tech executive John Miclot the keys to the corner office this week, following a tough third quarter that saw the resignation of former CEO Steven Nichtberger.

Nichtberger stepped down mid-August without official explanation.

Filed Under: News Well, Wall Street Beat Tagged With: Baxter, Personnel Moves, Precision Dynamics Corp., Tengion Inc., Ulthera Inc.

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS